Skip to content

REGN

Regeneron Pharmaceuticals, Inc.

Cash flow statement

Cash flow statement
Line, in USDLast 12 months202520242023202220212020201920182017201620152014201320122011201020092008
Operating cash flow4.85B4.98B4.42B4.59B5.01B7.08B2.62B2.43B2.20B1.31B1.49B1.33B0.75B0.59B−75M−0.14B99M−70M−89M
1.02B0.90B0.76B0.72B0.59B0.55B0.61B0.43B0.38B0.27B0.51B0.68B0.33B0.16B49M57M100M97M35M
Free cash flow3.83B4.08B3.66B3.88B4.42B6.53B2.00B2.00B1.81B1.03B0.97B0.65B0.42B0.43B−0.12B−0.20B−467K−0.17B−0.12B
Depreciation and amortization513M544M483M421M341M286M236M210M148M146M105M75M53M41M37M31M20M14M11M
Stock-based compensation1.01B0.99B0.98B0.89B0.73B0.60B0.43B0.46B0.43B0.51B0.56B0.46B0.32B0.22B94M56M40M31M33M
Buybacks3.04B3.44B2.60B2.24B2.08B1.65B5.85B0.28B4.4M00————————
Dividends paid383M370M00———————————————
Dividends per share3.70——————————————————
Free cash flow margin22.6%28.4%25.8%29.5%36.3%40.6%23.6%30.5%35.2%17.6%20.0%15.9%14.9%20.5%−9.0%−44.6%−0.1%−44.1%−52.0%